Immunophenotyping and differential diagnosis of hairy cell leukemia.
HCL and HCL-variant cells have a distinct immunophenotype that seems to correspond to that of a mature activated memory B cell. Although the two diseases have similarities in histology and membrane marker expression, such as the selected Ig heavy-chain expression and the reactivity with certain B-cell activation markers (eg, CD103), there are differences in their clinical course, morphology, and immunophenotype. Immunophenotyping is an essential tool for the diagnosis of these two disorders, for monitoring and assessing response to therapy, and for distinguishing them from other B-cell malignancies.
Matutes
Estella
E
Department of Haemato-Oncology, The Royal Marsden Hospital and Institute of Cancer Research, 203 Fulham Road, London, SW3 6JJ, UK. estella.matutes@icr.ac.uk
D001402:B-Lymphocytes / Q000378:metabolism / Q000473:pathology; D014408:Biomarkers, Tumor / Q000378:metabolism*; D001853:Bone Marrow / Q000378:metabolism / Q000473:pathology; D003937:Diagnosis, Differential; D007147:Immunoglobulin Light Chains / Q000378:metabolism*; D007142:Immunoglobulin gamma-Chains / Q000378:metabolism*; D016130:Immunophenotyping / Q000379:methods; D015448:Leukemia, B-Cell / Q000378:metabolism / Q000473:pathology; D007943:Leukemia, Hairy Cell / Q000378:metabolism* / Q000473:pathology*
D014408:Biomarkers, Tumor; D007147:Immunoglobulin Light Chains; D007142:Immunoglobulin gamma-Chains